StoreDot ends 2023 having achieved all its milestones and taken major steps towards commercialization and mass production This year saw it sign landmark agreements with strategic partners Volvo Cars, Polestar, VinFast and Flex|N|Gate 2023 also saw 15 leading global OEMs test its cells for six to nine months verifying outstanding performance and proceeding to B-sample projects with… Continue reading STOREDOT ENDS 2023 AS WORLD’S LEADING COMPANY MAKING EXTREME FAST CHARGING BATTERY TECHNOLOGY
Category: Newswire
AUTOCRYPT Partners With Hitachi Solutions on V2X and In-Vehicle Systems Security Solutions
SEOUL, South Korea, Dec. 7, 2023 /PRNewswire/ — AUTOCRYPT, an industry-leading automotive cybersecurity and mobility solutions company, announced its partnership with Hitachi Solutions, Ltd., a global IT service provider and system integrator. The two companies have agreed to provide joint offerings and consulting services covering V2X and in-vehicle systems security to Japanese automotive OEMs and… Continue reading AUTOCRYPT Partners With Hitachi Solutions on V2X and In-Vehicle Systems Security Solutions
High Performance Computing for Automotive
BOSTON, Dec. 7, 2023 /PRNewswire/ — Computers on wheels. That’s how people currently see cars. Practically everything that happens in a vehicle is being monitored and actuated by a microcontroller, from opening windows to calculating the optimal fuel-air mixture for the current torque demand. But the surface has only just been scratched in terms of how… Continue reading High Performance Computing for Automotive
Pozelimab Emerging Drug Insight and Market Forecasts, 2019-2032: An Investigational, Fully Human mAb Designed to Block Complement Factor C5 and Prevent the Destruction of Red Blood Cells
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Pozelimab Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about pozelimab for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the pozelimab for PNH in the 7MM, i.e., the United States, EU4 (Germany,… Continue reading Pozelimab Emerging Drug Insight and Market Forecasts, 2019-2032: An Investigational, Fully Human mAb Designed to Block Complement Factor C5 and Prevent the Destruction of Red Blood Cells
NCAA SCHOLARSHIP LIMIT CLASS ACTION INVESTIGATION: SILVER GOLUB & TEITELL LLP INVESTIGATING CLAIMS FOR DIVISION ONE SCHOLARSHIP ATHLETES
STAMFORD, Conn., Dec. 7, 2023 /PRNewswire/ — Silver Golub & Teitell LLP (“SGT”)—a Connecticut-based plaintiffs’ law firm with a national class action practice—is investigating whether the NCAA’s scholarship restrictions violate federal antitrust law. Multiple class actions have recently been filed. SGT believes that the NCAA’s limitations on the value of Division 1 athletic scholarships and… Continue reading NCAA SCHOLARSHIP LIMIT CLASS ACTION INVESTIGATION: SILVER GOLUB & TEITELL LLP INVESTIGATING CLAIMS FOR DIVISION ONE SCHOLARSHIP ATHLETES
FIII HONG KONG INVESTOR SUMMIT 7/8 DECEMBER BRINGS LEADERS TOGETHER TO ADDRESS HUMANITY’S BIGGEST CHALLENGES
RIYADH, Saudi Arabia, Dec. 7, 2023 /PRNewswire/ — The Future Investment Initiative PRIORITY Summit Hong Kong today convenes global investors, innovators and policymakers to tackle technology, climate, and economy threats. Investors and leaders from across Asia have gathered in Hong Kong with counterparts from around the world at an international summit to address global challenges,… Continue reading FIII HONG KONG INVESTOR SUMMIT 7/8 DECEMBER BRINGS LEADERS TOGETHER TO ADDRESS HUMANITY’S BIGGEST CHALLENGES
SOLIRIS Drug Insight and Market Forecasts, 2019-2032: The First Therapy Approved to Treat Patients with PNH
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “SOLIRIS Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about SOLIRIS for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the SOLIRIS for PNH in the 7MM, i.e., the United States, EU4 (Germany, France,… Continue reading SOLIRIS Drug Insight and Market Forecasts, 2019-2032: The First Therapy Approved to Treat Patients with PNH
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth – Technavio
NEW YORK, Dec. 7, 2023 /PRNewswire/ — The amyotrophic lateral sclerosis treatment market is expected to grow by USD 663.7 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 12.79% during the forecast period, according to Technavio Research. The market is segmented by Type (Intravenous and Oral), Distribution Channel… Continue reading Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth – Technavio
Citizen Watch America Celebrates Opening of Fifth Avenue CITIZEN FLAGSHIP STORE NEW YORK
The premiere retail destination offers an immersive shopping experience with Accutron, Alpina, Bulova, Citizen, and Frederique Constant brands NEW YORK, Dec. 7, 2023 /PRNewswire/ — Citizen Watch America (CWA), a leader in accessible luxury timepieces, marked the official opening of the group’s first-ever U.S.-based multi-brand flagship store yesterday evening. CITIZEN FLAGSHIP STORE NEW YORK, situated within… Continue reading Citizen Watch America Celebrates Opening of Fifth Avenue CITIZEN FLAGSHIP STORE NEW YORK
Fiji Airways partners with JetBlue
National Airline continues to grow its footprint in North America NADI, Fiji, Dec. 7, 2023 /PRNewswire/ — Fiji Airways, Fiji’s National Airline is proud to announce a new interline partnership with JetBlue based out of the United States. The partnership means guests can purchase fares on both airlines on the one ticket, seamlessly connecting customers between… Continue reading Fiji Airways partners with JetBlue